Federated Hermes’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-345,381
| Closed | -$297K | – | 2171 |
|
|
2023
Q4 | $297K | Sell |
345,381
-240,208
| -41% | -$206K | ﹤0.01% | 1453 |
|
|
2023
Q3 | $627K | Buy |
585,589
+104
| +0% | +$111 | ﹤0.01% | 1271 |
|
|
2023
Q2 | $1.52M | Buy |
585,485
+412,097
| +238% | +$1.07M | ﹤0.01% | 1043 |
|
|
2023
Q1 | $707K | Buy |
+173,388
| New | +$707K | ﹤0.01% | 1292 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$1K | – | 2358 |
|
|
2021
Q4 | $1K | Sell |
1
-6,627
| -100% | -$6.63M | ﹤0.01% | 2172 |
|
|
2021
Q3 | $139K | Sell |
6,628
-50
| -0.7% | -$1.05K | ﹤0.01% | 1728 |
|
|
2021
Q2 | $132K | Buy |
+6,678
| New | +$132K | ﹤0.01% | 1746 |
|
|
2020
Q4 | – | Sell |
-2,425
| Closed | -$39K | – | 2363 |
|
|
2020
Q3 | $39K | Sell |
2,425
-256
| -10% | -$4.12K | ﹤0.01% | 1816 |
|
|
2020
Q2 | $53K | Sell |
2,681
-625
| -19% | -$12.4K | ﹤0.01% | 1772 |
|
|
2020
Q1 | $41K | Sell |
3,306
-481
| -13% | -$5.97K | ﹤0.01% | 1718 |
|
|
2019
Q4 | $70K | Buy |
+3,787
| New | +$70K | ﹤0.01% | 1710 |
|